Paras Healthcare IPO: Listing Price, Subscription Status, Allotment & Dates

BSE/NSE · Mainboard

Listed

Paras Healthcare IPO at a glance

Opens
21 Oct 2026
Closes
23 Oct 2026
Allotment
26 Oct 2026
Listing
28 Oct 2026 · BSE/NSE
Price band
₹660 – ₹693
Lot size
21 shares (min ₹14,553)
Issue size
₹1,450 Cr
Registrar
MUFG Intime India Pvt Ltd

Subscription: QIB 3.25x · NII 0.69x · Retail 2.1x · Total 2.34x (as of 16 Nov 2026, 9:00 PM IST)

GMP: ₹13 (1.88% of upper band) · estimated listing price ₹706 (updated 16 Nov 2026, 9:00 PM IST)

GMP is unofficial grey-market data and the listing estimate is simply upper band + GMP — not a prediction or advice.

Price Band

₹660 - ₹693

Lot Size

21 shares

Min ₹14,553

Issue Size

₹1,450 Cr

GMP (Grey Market)

₹13

1.9% premium

Important Dates

Open Date

21 Oct 2026

Close Date

23 Oct 2026

Allotment

26 Oct 2026

Listing

28 Oct 2026

Subscription Status

Retail
2.1x
NII
0.7x
QIB
3.3x
Total2.3x

Day-by-Day Subscription

DayQIBNIIRetailEmployeeTotal
Day 1 (24 Oct 2026)3.25x0.69x2.10x0.00x2.34x
Day 2 (25 Oct 2026)3.25x0.69x2.10x0.00x2.34x
Day 3 (26 Oct 2026)3.25x0.69x2.10x0.00x2.34x
Day 4 (27 Oct 2026)3.25x0.69x2.10x0.00x2.34x

GMP History

DateGMP (₹)GMP (%)
15 Oct 2026₹11516.6%
16 Oct 2026₹9714.0%
17 Oct 2026₹9613.8%
18 Oct 2026₹9213.3%
19 Oct 2026₹8412.1%
20 Oct 2026₹507.2%
21 Oct 2026₹355.0%
22 Oct 2026₹131.9%
23 Oct 2026₹111.6%
24 Oct 2026₹121.7%
25 Oct 2026₹121.7%
26 Oct 2026₹111.6%
27 Oct 2026₹172.5%
28 Oct 2026₹131.9%
29 Oct 2026₹131.9%
30 Oct 2026₹131.9%
31 Oct 2026₹131.9%
1 Nov 2026₹131.9%
2 Nov 2026₹131.9%
3 Nov 2026₹131.9%
4 Nov 2026₹131.9%
5 Nov 2026₹131.9%
6 Nov 2026₹131.9%
14 Nov 2026₹131.9%
15 Nov 2026₹131.9%
16 Nov 2026₹131.9%

Paras Healthcare IPO allotment status

The basis of allotment is expected on 26 Oct 2026. The registrar to the issue is MUFG Intime India Pvt Ltd. Once allotment is final, shares are credited to your demat account before listing, and the blocked amount is released if you are not allotted.

Check allotment on the MUFG Intime India Pvt Ltd website →

Full allotment guide for Paras Healthcare →

Paras Healthcare IPO listing date

Paras Healthcare listed on 28 Oct 2026 on BSE/NSE. It listed at ₹720, +3.9% versus the ₹693 upper band.

Financial Performance

MetricFY24FY25FY26
Revenue (₹ Cr)1,129.041,294.061,605.95
Profit (₹ Cr)-15.33-57.9843.83
Total Assets (₹ Cr)1,477.661,810.452,017.14

As disclosed by Paras Healthcare in its offer document.

Strengths and risks

Taken from Paras Healthcare's own offer document — not Arthneeti's assessment.

  • ✓As of June 30, 2026, the company operated eight hospitals with an aggregate bed capacity of 2,211 beds across five states and one Union Territory. It claims to have an early-mover advantage in several markets, including being the first corporate hospital entrant among its listed peers in Gurugram and Patna.
  • !The company incurred losses of Rs 57.98 crore and Rs 15.33 crore in FY25 and FY24, respectively, and Rs 1.02 crore in the three months ended June 30, 2025. These losses were primarily attributable to the ramp-up of its Srinagar and Kanpur hospitals and investments in bed capacity expansion and clinical programmes across its hospital network. Although the company reported a profit of Rs 43.83 crore in FY26, any failure to increase revenue sufficiently to cover expenses and sustain profitability could adversely affect its financial performance.
  • ✓The company focuses on cardiac sciences, oncology, neurosciences, gastro sciences, orthopaedics and sports injury, and renal sciences. These specialities contributed 74.70% of its revenue from operations in FY26, compared with 72.34% in FY24.
  • !The company’s subsidiaries, Paras Healthcare (Ranchi) Private Limited and Plus Medicare Hospitals Private Limited, collectively incurred losses of Rs 20.38 crore, Rs 52.09 crore, Rs 82.24 crore, and Rs 87.27 crore in the three months ended June 30, 2025, FY26, FY25, and FY24, respectively. These losses were attributed to the ramp-up of the Ranchi and Srinagar hospitals and increased fixed and operating expenses following the expansion of bed capacity at the Ranchi hospital. Any failure of these subsidiaries to achieve profitability or raise adequate capital to meet their obligations could adversely affect the company’s financial performance.

12 more points from Paras Healthcare's offer document

About Paras Healthcare

Paras Healthcare is a hospital operator providing tertiary and quaternary healthcare services through a network of eight hospitals under the Paras Health brand. As of June 30, 2026, the company was present in five states and one Union Territory. Its hospitals are located in Gurugram and Panchkula in Haryana, Patna and Darbhanga in Bihar, Kanpur in Uttar Pradesh, Udaipur in Rajasthan, Ranchi in Jharkhand, and Srinagar in Jammu and Kashmir. The company provides treatments across several clinical specialities, including cardiac sciences, oncology sciences, neurosciences, gastro sciences, orthopaedics and sports injury, and renal sciences. As of June 30, 2026, its hospital network had 1,084 doctors and 1,937 nurses. Use of proceeds: The IPO consists of both a fresh issue of shares and an offer for sale (OFS).​ Proceeds from the OFS will go to the respective selling shareholders, whereas the net proceeds from the fresh issue will be utilised for the following purposes:​ Prepayment or scheduled repayment, in full or part, of certain outstanding borrowings availed by the company — Rs 320.90 crore Investment in the wholly owned subsidiary, PMHPL, for repayment/prepayment of borrowings, in full or part, of PMHPL — Rs 54.10 crore General corporate purposes

Go deeper on Paras Healthcare

See Arthneeti's AI earnings-call analysis, quarterly financials and quarter rank for Paras Healthcare.

View Paras Healthcare research →

GMP data is indicative and sourced from grey market. Subscription data is from exchange filings. This is not investment advice. Please consult a SEBI-registered advisor before investing.